Triplet Chemotherapy with Cisplatin versus Oxaliplatin in the CRITICS Trial: Treatment Compliance, Toxicity, Outcomes and Quality of Life in Patients with Resectable Gastric Cancer

SIMPLE SUMMARY: Perioperative chemotherapy is the current standard treatment for patients with resectable gastric cancer. Either cisplatin or oxaliplatin could be part of the chemotherapy regimen, of which oxaliplatin is currently most used in the standard treatment. Evidence to choose oxaliplatin o...

Descripción completa

Detalles Bibliográficos
Autores principales: Slagter, Astrid E., Caspers, Irene A., van Grieken, Nicole C. T., Walraven, Iris, Lind, Pehr, Meershoek-Klein Kranenbarg, Elma, Grootscholten, Cecile, Nordsmark, Marianne, van Sandick, Johanna W., Sikorska, Karolina, van de Velde, Cornelis J. H., Jansen, Edwin P. M., Verheij, Marcel, van Laarhoven, Hanneke W. M., Cats, Annemieke
Formato: Online Artículo Texto
Lenguaje:English
Publicado: MDPI 2022
Materias:
Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9221508/
https://www.ncbi.nlm.nih.gov/pubmed/35740628
http://dx.doi.org/10.3390/cancers14122963

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9221508/
https://www.ncbi.nlm.nih.gov/pubmed/35740628
http://dx.doi.org/10.3390/cancers14122963

Ejemplares similares